Shares of Rossari Biotech have risen over 11% in the last three trading sessions, following the company's Annual General Meeting on May 31,...

Manappuram Finance and Rossari Biotech shares traded ex-dividend on May 24. Manappuram had earlier announced an interim dividend of Re 0.75...

In the longer run, under normalized operating conditions, the brokerage expects the operating margins to restore to 14-15% levels. In addit...

Domestic brokerage YES Securities sees continuation in growth momentum on the back of multiple acquisitions, along with improvement in marg...

Rossari Biotech Ltd., incorporated in the year 2009, is a Small Cap company (having a market cap of Rs 4931.95 Crore) operating in Chemical...

The target company is among the major producers of perfumery chemicals, dye Intermediates and high-tech distillation products. It caters to...

Rossari will initially acquire 65 per cent equity stake in Unitop Chemicals, while the remainder 35 per cent stake will be bought over the ...

Plutus Wealth Management bought 3,00,000 shares of Rossari Biotech at Rs 773.82 per share.

A total of 536,785 shares changed hands on the counter till 10:40AM (IST).

Here’s who bought and sold what in some of the key bulk deals of the day.

The specialty chemicals maker will debut on the bourses on Thursday, the first after the SBI Card around four months ago.

The company is among the largest manufacturers of textile specialty chemicals in India.

The IPO would be a mix of fresh issue and offer for sale (OFS).

This would be the first company to brave the current volatile markets.

The company was likely to launch its IPO on March 18.

The IPO comprises a fresh issue of Rs 150 crore and OFS of up to 1,05,00,000 equity shares.

The issue will comprise a fresh issue of Rs 150 crore and OFS of up to 1.05 crore shares.